These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 2040178

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparative pharmacokinetics of recombinant erythropoietin administered by the intravenous, subcutaneous, and intraperitoneal routes in continuous ambulatory peritoneal dialysis (CAPD) patients.
    Boelaert JR, Schurgers ML, Matthys EG, Belpaire FM, Daneels RF, De Cre MJ, Bogaert MG.
    Perit Dial Int; 1989; 9(2):95-8. PubMed ID: 2488207
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy of once- versus thrice-weekly subcutaneous recombinant human erythropoietin in children receiving continuous cycling peritoneal dialysis.
    Ongkingco JR, Ruley EJ, Turner ME, Fragale MR.
    Am J Nephrol; 1994; 14(1):14-8. PubMed ID: 8017476
    [Abstract] [Full Text] [Related]

  • 9. [The pharmacokinetics of recombinant human erythropoietin].
    Siniukhin VN, Stetsiuk EA, Lovchinskiĭ EV, Lebedev SV, Iarmolinskiĭ IS, Liakhov VV.
    Ter Arkh; 1994; 66(8):60-2. PubMed ID: 7985158
    [No Abstract] [Full Text] [Related]

  • 10. Subcutaneous recombinant human erythropoietin in children with renal anemia on continuous ambulatory peritoneal dialysis.
    Aufricht C, Balzar E, Steger H, Lothaller MA, Frenzel K, Kohlhauser C, Kiss H, Khoss AE, Kernova T.
    Acta Paediatr; 1993 Nov; 82(11):959-62. PubMed ID: 8111178
    [Abstract] [Full Text] [Related]

  • 11. Stepwise correction of anaemia by subcutaneous administration of human recombinant erythropoietin in patients with chronic renal failure maintained by continuous ambulatory peritoneal dialysis.
    Stevens JM, Auer J, Strong CA, Hughes RT, Oliver DO, Winearls CG, Cotes PM.
    Nephrol Dial Transplant; 1991 Nov; 6(7):487-94. PubMed ID: 1922910
    [Abstract] [Full Text] [Related]

  • 12. [Multicenter study of darbepoetin alfa in the treatment of anemia secondary to chronic renal insufficiency on dialysis].
    Martínez Castelao A, Reyes A, Valdés F, Otero A, López de Novales E, Pallardó L, Tabernero JM, Hernández Jaras J, Lladós F.
    Nefrologia; 2003 Nov; 23(2):114-24. PubMed ID: 12778875
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Use of low-dose subcutaneous recombinant human erythropoietin in end-stage renal disease: experience with children receiving continuous cycling peritoneal dialysis.
    Ongkingco JR, Ruley EJ, Turner ME.
    Am J Kidney Dis; 1991 Oct; 18(4):446-50. PubMed ID: 1928063
    [Abstract] [Full Text] [Related]

  • 15. Correction of anemia using self-administered daily subcutaneous erythropoietin in uremic patients on continuous ambulatory peritoneal dialysis.
    Li PK, Leung CB, Lui SF, Leung JC, Shek AC, Lai KN.
    Int J Artif Organs; 1993 Jul; 16(7):510-4. PubMed ID: 8370605
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of recombinant human erythropoietin in children treated with continuous ambulatory peritoneal dialysis.
    Reddingius RE, Schröder CH, Koster AM, Monnens LA.
    Eur J Pediatr; 1994 Nov; 153(11):850-4. PubMed ID: 7843202
    [Abstract] [Full Text] [Related]

  • 17. Subcutaneous administration of recombinant human erythropoietin to subjects on continuous ambulatory peritoneal dialysis: an erythrokinetic assessment.
    Hughes RT, Cotes PM, Pippard MJ, Stevens JM, Oliver DO, Winearls CG, Royston JP.
    Br J Haematol; 1990 Jun; 75(2):268-73. PubMed ID: 2372513
    [Abstract] [Full Text] [Related]

  • 18. Daily self-administered subcutaneous erythropoietin: benefits in haemodialysis patients.
    Granolleras C, Branger B, Deschodt G, Shaldon S, Nonnast-Daniel B, Pollok M.
    Contrib Nephrol; 1990 Jun; 82():49-54. PubMed ID: 2093526
    [No Abstract] [Full Text] [Related]

  • 19. One year's experience with recombinant erythropoietin in children undergoing continuous ambulatory or cycling peritoneal dialysis.
    Offner G, Hoyer PF, Latta K, Winkler L, Brodehl J, Scigalla P.
    Pediatr Nephrol; 1990 Sep; 4(5):498-500. PubMed ID: 2242315
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics and pharmacodynamics of subcutaneous and intraperitoneal administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
    Lui SF, Chung WW, Leung CB, Chan K, Lai KN.
    Clin Nephrol; 1990 Jan; 33(1):47-51. PubMed ID: 2302870
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.